As nicotine pouches become more widely available, attention is increasingly turning to the ingredients used in these products and how they behave during use. While the absence of tobacco combustion is an important distinction from cigarettes, it does not eliminate the need to assess potential chemical exposure. A study published in the October 2026 issue…
The evidence base around oral nicotine pouches is developing rapidly. A major updated scoping review published in Nicotine & Tobacco Research in September 2026 provides one of the broadest assessments so far, examining research on product characteristics, patterns of use, nicotine delivery, toxicity, marketing and potential public-health effects. The review identified 73 new studies, bringing…
Sweden presents an unusual picture in European nicotine policy. Daily cigarette smoking has fallen to historically low levels, while the use of other nicotine products, particularly snus and nicotine pouches, remains considerably more common. According to Sweden’s Public Health Agency, 5.4% of people aged 16–84 reported smoking tobacco daily in 2024. At the same time,…
A recent JAMA Insights article on nicotine pouches provides a useful overview of the concerns and unanswered questions surrounding a rapidly growing category of smoke-free nicotine products. Published in 2026 by Thomas M. Piasecki, Megan E. Piper and Hasmeena Kathuria, the article examines patterns of nicotine pouch use in the United States, nicotine exposure, potential…
Sweden’s unusually low smoking prevalence has long attracted international attention. Much of the discussion has focused on the country’s long history of snus use, particularly among men. But Sweden’s nicotine market is changing. Tobacco-free nicotine pouches have grown rapidly, and their uptake among women raises a new question: could a product category with broader appeal…
The evidence surrounding oral nicotine pouches has expanded rapidly. Questions that only a few years ago were being considered using a relatively small body of research can now be examined across studies covering product characteristics, nicotine delivery, toxicant exposure, patterns of use, smoking behaviour, marketing and consumer perceptions. For regulators, this expanding evidence base creates…
Nicotine markets can change faster than the systems designed to monitor them. New products enter the market, public-health controversies emerge, regulations change and consumers encounter new information online, sometimes long before conventional surveys can provide a clear picture of what is happening. This creates a challenge for regulators trying to develop policies based on current…
Nicotine pouches are increasingly caught between two competing public-health narratives. One presents them as smoke-free alternatives that could reduce harm among adults who would otherwise continue smoking. The other focuses on their potential to introduce nicotine to young people and people who have never used nicotine. A new pharmacy-focused review accepted by the Journal of…
Questions about the oral health effects of nicotine pouches have become increasingly important as their use expands. The evidence remains limited, particularly when it comes to longer-term outcomes, but a newly published Swedish clinical study adds useful data to the discussion. Published in Clinical Oral Investigations on 22 August 2026, researchers from the University of…
Youth nicotine policy often begins with a straightforward objective: prevent young people from starting to use nicotine. The harder question is how. Smoking, vaping and nicotine pouch use are sometimes grouped together in prevention strategies because they all involve nicotine. Yet young people may encounter these products in different settings, perceive them differently and respond…